At the 12 mg dose level, here is what clinical trials reported: Nausea: 43.2% of participants (versus 10.7% on placebo) Diarrhea: 33.1% of participants (versus 13.4% on placebo) Constipation: 25.0% of participants (versus 8.7% on placebo) Vomiting: 20.9% of participants These percentages tell an important story
The combination of nutrients in MIC B12 shots may help improve fat metabolism, increase energy levels, and support liver function
Understanding the daily B12 supplement risks can help avoid complications, especially for older adults or those on multiple medications
This subclinical deficiency phase is associated with low or marginal vitamin B12 concentrations
38 , 115 , 116 , 129 - 135 Thus, it may be that BPC 157 does modulate dopamine system activity
This may have increased results